Pseudomyxoma Peritonei Originating from Transverse Colon Mucinous Adenocarcinoma: A Case Report and Literature Review

Figure 4

Representative drugs for MAPK/ERK pathway and BRAF v600E mutation for potential therapy of PMP from mCRC.